Catalyst Wire Dossier Catalyst Wire Dossier

Revaxis

Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus Vaccine · Sanofi Pasteur
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Revaxis, covering 2016-09-07 to 2017-09-11. Get the full timeline:

Most recent: Clinical Trial Update: REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children [Phase 3]

See pricing